GlassScriptPhysician profile
Stacey Hollaway
NPI 1922064906
$15,488.89
in general payments reported to CMS, 2019-2025
63 companies · $2,250 in 2025
The $2,250 reported for 2025 was more than what 94% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,053 · 2020: $1,936 · 2021: $3,044 · 2022: $1,924 · 2023: $2,041 · 2024: $2,241 · 2025: $2,250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,531.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,609.85 | 2019-2025 | |
| Novo Nordisk INC | $1,712.47 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,386.12 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Pfizer INC. | $1,105.35 | 2019-2025 | |
| Glaxosmithkline, LLC. | $917.79 | 2019-2024 | Arexvy, Trelegy Ellipta, Shingrix |
| Lilly USA, LLC | $700.94 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Supernus Pharmaceuticals, INC. | $460.62 | 2019-2025 | Qelbree |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $448.58 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $406.25 | 2019-2025 | Trintellix |
| Allergan, INC. | $400.36 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $392.60 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $359.17 | 2020-2024 | Jardiance, Ofev |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $275.92 | 2025 | Caplyta |
| Gilead Sciences, INC. | $274.67 | 2019-2023 | |
| Ironshore Pharmaceuticals INC. | $271.92 | 2019-2024 | Jornay Pm |
Show all 63 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $264.59 | 2023-2025 | Cologuard Collection Kit |
| Phathom Pharmaceuticals, INC. | $259.23 | 2024-2025 | Voquezna |
| Corium, LLC | $258.45 | 2022-2024 | Azstarys |
| Sanofi Pasteur INC. | $215.43 | 2019-2025 | |
| Idorsia Pharmaceuticals US INC | $199.99 | 2022-2023 | Quviviq |
| Astellas Pharma US INC | $191.38 | 2019-2023 | Veozah, Myrbetriq |
| Amgen INC. | $184.04 | 2019-2025 | Evenity, Repatha, Prolia |
| Almatica Pharma LLC | $180.89 | 2022-2023 | Loreev Xr |
| Sanofi-Aventis U.S. LLC | $174.03 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $138.37 | 2019 | |
| Horizon Therapeutics Plc | $118.99 | 2022 | |
| Abbott Laboratories | $114.09 | 2022-2025 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $104.57 | 2019-2025 | Gardasil 9, Vaxneuvance, Capvaxive |
| Eisai INC. | $103.70 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $78.40 | 2021-2025 | |
| Aimmune Therapeutics, INC. | $74.92 | 2024-2025 | Zenpep |
| Janssen Pharmaceuticals, INC | $73.92 | 2019-2021 | |
| Genentech USA, INC. | $72.51 | 2019-2021 | |
| Xeris Pharmaceuticals, INC. | $66.17 | 2024-2025 | Gvoke Hypopen |
| Biohaven Pharmaceutical Holding Company LTD. | $63.78 | 2022 | |
| Optinose US, INC. | $56.50 | 2024-2025 | |
| Nestle Healthcare Nutrition INC. | $56.01 | 2022-2023 | |
| Corcept Therapeutics | $46.55 | 2021 | |
| Amarin Pharma, INC. | $44.46 | 2019-2020 | |
| Ibsa Pharma INC. | $44.12 | 2021-2023 | Tirosint, Licart |
| Axsome Therapeutics, INC. | $37.94 | 2025 | Auvelity |
| Vivus LLC | $36.04 | 2024-2025 | Qsymia |
| Collegium Pharmaceutical, INC. | $34.91 | 2025 | Jornay Pm |
| Vbi Vaccine (Delaware) INC. | $34.28 | 2022 | |
| Inspire Medical Systems, INC. | $33.88 | 2024-2025 | Inspire |
| E.R. Squibb & Sons, L.L.C. | $33.06 | 2022-2023 | Camzyos |
| Lundbeck LLC | $32.44 | 2025 | Rexulti |
| Ironwood Pharmaceuticals, INC | $30.02 | 2020 | |
| Tris Pharma INC | $29.40 | 2024-2025 | Dyanavel Xr |
| Teva Pharmaceuticals USA, INC. | $28.92 | 2020 | |
| Currax Pharmaceuticals LLC | $26.57 | 2023 | Contrave |
| Radius Health, INC. | $26.25 | 2019 | |
| Adlon Therapeutics L.P. | $26.23 | 2019-2021 | |
| Grifols USA, LLC | $22.31 | 2025 | Prolastin-C Liquid |
| Ardelyx, INC. | $20.08 | 2025 | Ibsrela |
| Biohaven Pharmaceuticals, INC. | $20.00 | 2021 | |
| Dermira, INC. | $18.83 | 2019 | |
| Vertical Pharmaceuticals, LLC | $18.15 | 2019 | |
| Sumitomo Pharma America, INC. | $16.20 | 2024 | Gemtesa |
| Neos Therapeutics, LP | $16.13 | 2019 | |
| Noven Therapeutics, LLC | $14.75 | 2025 | Xelstrym |
| Seqirus USA INC | $12.98 | 2022 | |
| Bausch Health US, LLC | $11.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Hollaway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.